Company: BGLC
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001477932-25-008343
Chunk: 29

Company: BioNexus Gene Lab Corp
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 1
Chunk 29
---
 months ended September 30, 2025, and 2024, respectively, the suppliers who accounted for 10% or more of the Company’s cost of sales and their balances at period ended are presented as follows:   2025  2024  2025  2024  2025  2024   Purchase  Percentage of purchases  Accounts payable trade Vendor A $407,648  $386,895   18.82%  16.79% $-  $317,624 Vendor B $380,771  $586,206   17.58%  25.44% $94,145  $177,783 Vendor C $230,019  $-   10.62%  -  $-  $- Vendor D $-  $347,281   -   15.07% $-  $313,016   $1,018,438  $1,320,382   47.02%  57.30% $94,145  $808,423  a) Major customers For nine months ended September 30, 2025, and 2024, the Company did not have any material recognizable major customers accounted for 10% or more of the Company’s revenue  b) Major suppliers For nine months ended September 30, 2025, and 2024, respectively, the suppliers who accounted for 10% or more of the Company’s cost of sales and their balances at period ended are presented as follows:   2025  2024  2025  2024  2025  2024   Purchase  Percentage of purchases  Accounts payable trade Vendor A $1,494,227  $1,058,928   25.53%  17.63% $-  $317,624 Vendor B $939,970  $1,069,272   16.06%  17.80% $94,145  $177,738 Vendor C $-  $968,574   -   16.13% $-  $313,016   $2,434,197  $3,096,